Investors
Partners
Our Pipeline

We are building a pipeline of compelling investigational therapies targeting indications for which we believe gene therapy can have the greatest impact in patients with rare genetic diseases.

Our Products

Hunterase®, (iduronidase-2-sulfatase) is a recombinant human Enzyme Replacement Therapy (ERT).

Corporate Culture & Career

To be a global biopharmaceutical company delivering life-changing therapeutics built upon a foundation in China

Contact Us
Beijing
Beijing
Suite 301,3F,Timeloit, No. 17 RongChuang Road, Chaoyang District, Beijing, China
Tel: 010 84148018
Fax: 010 84148017
Adverse Events Reporting: PV@canbridgepharma.com
Shanghai
Shanghai
Suite 708, Huawen International Mansion, No.999, West Zhongshan Road, Changning District, Shanghai
Tel: 021 52956319
Fax: 021 52665300
Adverse Events Reporting: PV@canbridgepharma.com
Hong Kong
Hong Kong
Unit A131, 16/F, Sun Life Tower, The Gateway, Harbour City, 15 Canton Road, Tsim Sha Tsui
Taiwan
Taiwan
Room B06, 11F, No.281, Sec. 4, Xinyi Road, Da'an District, Taipei, 10681, Taiwan
Hangzhou
Hangzhou
Room 2506, Building 2, Qianjiang International Times Plaza, 111 Chengxing Road, Jianggan District, Hangzhou City, Zhejiang Province,China
Tel: 0571 88210026
Fax: 0571-88210207
Cambridge
Cambridge
139 Main Street, Suite 100, Cambridge, MA 02142, USA